Method for treating dystonia with botulinum toxin type B

Details for Australian Patent Application No. 2005200248 (hide)

Owner Allergan, Inc.

Inventors Not Given

Agent Davies Collison Cave

Pub. Number AU-A-2005200248

Parent 29234

Filing date 21 January 2005

Wipo publication date 17 February 2005

Acceptance publication date 15 February 2007

International Classifications

A61K 038/48 Medicinal preparations containing peptides

A61P 021/00 Drugs for disorders of the muscular or neuromuscular system

Event Publications

3 February 2005 Complete Application Filed

17 February 2005 Application Open to Public Inspection

  Published as AU-A-2005200248

15 February 2007 Application Accepted

  Published as AU-A-2005200248

10 May 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 15 Mar 2007. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000 2006

14 June 2007 Standard Patent Sealed

13 September 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Mar 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200249-Method and apparatus for multi-sensory speech enhancement on a mobile device

2005200247-Method and system for applying absorbent material to a substrate